CWBHF on OTC

Charlotte's Web Holdings, Inc.

Charlotte's Web Holdings, Inc. is a Canadian agricultural production-crops company based in Louisville.2 Its shares trade on OTC under the symbol CWBHF.2

Price unavailable

Last updated Oct 20, 2026.

Overview

Compare with Local Bounti Corporation/DE, Insignia Systems, Inc. or Grown Rogue International Inc., or pick any stock.

  • TickerCWBHF on OTC2
  • IndustryAgricultural Production-Crops2
  • HeadquartersBoulder, United States2
  • Incorporated inBritish Columbia, Canada3
  • Business address700 Tech Court, Louisville, Co 800273
  • Filer category, Emerging growth company3
  • Legal formCorporation2
  • LEI5493008O89WUQELR8M882
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered address2800 Park Place, V6C 2X8 Vancouver, Canada2
  • Registered withBC Registry Services, BC11648202

Charlotte's Web Holdings, Inc., ("Charlotte's Web", the "Company" or "we"), a benefit company under the Business Corporations Act (British Columbia) ("BCBCA"), S.B.C. 2002, c. 57, as amended, including the regulations promulgated thereunder, headquartered in Louisville, Colorado, was incorporated under the BCBCA on May 18, 2018 under the name Stanley Brothers Holdings Inc. On July 12, 2018, the Company changed its name to Charlotte's Web Holdings, Inc. On August 29, 2018, the Company filed articles of amendment to amend its share capital in connection with its initial public offering to authorize the issuance of common shares ("Common Shares"), preferred shares and proportionate voting shares ("Proportionate Voting Shares") of the Company. On November 3, 2021, all outstanding Proportionate Voting Shares of the Company were converted by way of mandatory conversion in accordance with the C…5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

43.5%Gross margin6
-40.6%Operating margin6
-59.6%Net margin6
0.5%Revenue growth, 20256

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue39¢$28.2M
  • Research and development3¢$1.8M
  • Selling, general and admin58¢$42.0M
  • Income tax0¢$68.0K

Out of $49.9M in revenue.6 The company lost money this year.

Financial statements

Revenue789106$49.9M in 2025−48% since 2020
0$25.0M$50.0M$75.0M$100.0M2020: $95.2M$95.2M20202021: $96.1M$96.1M2021+1%2022: $74.1M$74.1M2022−23%2023: $63.2M$63.2M2023−15%2024: $49.7M$49.7M2024−21%2025: $49.9M$49.9M2025+0%
Gross profit789106$21.7M in 2025−58% since 2020
0$20.0M$40.0M$60.0M2020: $52.3M$52.3M20202021: $48.6M$48.6M2021−7%2022: $19.4M$19.4M2022−60%2023: $35.6M$35.6M2023+83%2024: $21.3M$21.3M2024−40%2025: $21.7M$21.7M2025+2%
Operating income789106-$20.3M in 2025−61% since 2020
-$150.0M-$100.0M-$50.0M02020: -$51.3M-$51.3M20202021: -$147.1M-$147.1M2021+186%2022: -$52.5M-$52.5M2022−64%2023: -$40.6M-$40.6M2023−23%2024: -$32.0M-$32.0M2024−21%2025: -$20.3M-$20.3M2025−37%
Net income789106-$29.7M in 2025−3% since 2020
-$150.0M-$100.0M-$50.0M02020: -$30.7M-$30.7M20202021: -$137.7M-$137.7M2021+349%2022: -$59.3M-$59.3M2022−57%2023: -$23.8M-$23.8M2023−60%2024: -$29.8M-$29.8M2024+25%2025: -$29.7M-$29.7M2025−0%

Every line of the income statement as filed: the last 2 fiscal years, latest first.6

Period ending2025-12-312024-12-31
Revenue$49.9M$49.7M
Cost of goods sold$28.2M$28.4M
Gross profit$21.7M$21.3M
Selling, general and administrative expenses$42.0M$53.2M
Operating loss-$20.3M-$32.0M
Change in fair value of financial instruments-$7.3M$615.0K
Other income (expense), net-$2.3M$1.6M
Loss before provision for income taxes-$29.8M-$29.8M
Income tax benefit (expense)$68.0K-$39.0K
Net loss-$29.7M-$29.8M
Net loss per common share, basic (in usd per share)-$0.19-$0.19
Net loss per common share, diluted (in usd per share)-$0.19-$0.19

Compare Charlotte's Web Holdings, Inc. with another company

Corporate structure

Charlotte's Web Holdings, Inc. sits at the top of its group. 5 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Charlotte's Web Holdings, Inc.

  • BT DE Investments Inc. Filed SCHEDULE 13D/A on Charlotte's Web Holdings, Inc., latest May 29, 2026 (3 filings since Nov 23, 2022)
  • Joel Stanley Filed SC 13D on Charlotte's Web Holdings, Inc., latest Jun 16, 2023
  • Charlotte's Web Holdings, Inc. Boulder, Colorado, United States
    • • Abacus Health Products, Inc. Subsidiary · Delaware, United States
    • • Abacus Products, Inc. Subsidiary · British Columbia, Canada
    • • Abacus Wellness, Inc. Subsidiary · Delaware, United States
    • • Charlotte’s Web, Inc. Subsidiary · Delaware, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Charlotte's Web Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Accumulated depreciation$30.9M6 Dec 31, 2025$27.2M6 Dec 31, 2024+13.7%
Property and equipment, net$22.7M6 Dec 31, 2025$26.3M6 Dec 31, 2024−13.9%
Operating-lease assets (leased space)$11.3M6 Dec 31, 2025$12.9M6 Dec 31, 2024−12.3%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$8.0M6 Dec 31, 2025$22.6M6 Dec 31, 2024−64.5%
Stakes in other companies (equity method)$8.8M6 Dec 31, 2025$10.8M6 Dec 31, 2024−18.5%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$785.0K6 Dec 31, 2025$1.0M6 Dec 31, 2024−25.2%
Indefinite-lived intangibles (excluding goodwill)$313.0K6 Dec 31, 2025$301.0K6 Dec 31, 2024+4.0%
Finite-lived intangibles, gross$3.5M6 Dec 31, 2025$3.7M6 Dec 31, 2024−4.0%
Accumulated amortization$3.1M6 Dec 31, 2025$2.9M6 Dec 31, 2024+4.3%
Finite-lived intangibles, net$472.0K6 Dec 31, 2025$748.0K6 Dec 31, 2024−36.9%

Inventory

ItemLatestA year beforeChange
Inventory, total$18.0M6 Dec 31, 2025$18.9M6 Dec 31, 2024−4.7%
Raw materials$10.4M6 Dec 31, 2025$11.9M6 Dec 31, 2024−12.8%
Work in process$2.2M6 Dec 31, 2025$2.3M6 Dec 31, 2024−4.3%
Finished goods$6.6M6 Dec 31, 2025$6.3M6 Dec 31, 2024+5.4%

Properties, in its own words

The following table sets forth the Company’s principal physical properties used in its single operating and reportable segment.

Material Properties

The rest of Item 2

Type · Location · Leased / Owned

Manufacturing, Production, Research and Development · 700 Tech Court, Louisville, Colorado · Leased

Office · 1801 California Street, Denver, Colorado* · Sublease

Office · 1600 Pearl Street, Boulder, Colorado* · Lease was terminated as of August 31, 2025

*As of September 1, 2024, the Company executed a sublease agreement to cover a portion of its obligations concerning 1801 California Street property.

Facilities Overview

The Company operates several Colorado-based facilities to house administrative work, processing, R&D, distribution, horticulture, breeding and greenhouse space. In 2019, the Company leased a 136,610-square-foot industrial building located at 700 Tech Court in the Colorado Technology Center in Louisville, Colorado. This cGMP facility, the LOFT, enables the Company for production, distribution, quality control and R&D expansion. This facility was used for supply chain activities commencing in the second quarter of 2020 and manufacturing and operations commencing in the third quarter of 2020.

Through its subsidiaries, the Company has entered into material lease agreements related to its operations. Those agreements are discussed below.

700 Tech Court

On May 7, 2019, EJ 700 Tech Court LLC entered into a lease agreement with Charlotte’s Web, Inc. for a period of 126 months commencing on September 1, 2019 for the premises located at the LOFT at 700 Tech Court, Louisville, Colorado (the "Tech Court Lease Agreement"), a cGMP facility. Following a lease abatement period for the first six months of no monthly rent payments, the monthly base rent for the remainder of the term of the lease is an average of $143,732 per month. The foregoing description is qualified in its entirety by reference to the Tech Court Lease Agreement.

1801 California Street

On May 11, 2021, Molson Coors Beverage Company ("Molson Coors"), as tenant and sublandlord, and Charlotte’s Web, Inc., as subtenant, entered in a sublease agreement covering and describing the premises known as the entire 47th floor of a building located at 1801 California Street in Denver, Colorado comprising 22,389 rentable square feet (the "1801 California Sublease"), leased by Molson Coors from BOP 1801 California Street II LLC and BPREP 1801 California Street JV, LLC (collectively, as the landlord), in that certain Lease of Office Space agreement dated November 26, 2014, as amended from time-to-time. Pursuant to the terms of the 1801 California Sublease, the term of the sublease was to begin on July 1, 2021 and end on March 31, 2027. The 1801 California Sublease contained a lease abatement provision for the first seven months with no rent due, and a monthly base rent for the remainder of the first 12 months of the lease term of $37,315.00. The foregoing description is qualified in its entirety by reference to the 1801 California Sublease.

On June 15, 2021, Molson Coors and the Company entered into that certain First Amendment to Sublease Agreement (the "First Amendment to the 1801 California Sublease"), whereby the Company agreed to sublease the 48th floor of 1801 California Street given that the 47th floor as contemplated in the 1801 California Sublease was unavailable to the Company. The First Amendment to the 1801 California Sublease contained same rent abatement term for the first seven months of the lease term, and thereafter includes a monthly installment for the term of the lease of approximately $39,269. The foregoing description is qualified in its entirety by reference to the First Amendment to the 1801 California Sublease.

On May 24, 2024, Charlotte’s Web, Inc. and Bachus & Schanker, LLC (“B&S”). entered into a sublease agreement whereby Charlotte’s Web, Inc. agreed to sublease to B&S, as subtenant, the entirety of the rentable square feet under the 1801 California Sublease. The B&S Sublease Agreement average monthly installment for the term of the lease is $31,289. The foregoing description is qualified in its entirety by reference to the B&S Sublease Agreement.

1600 Pearl Street

On May 12, 2021, Charlotte’s Web, Inc. and Outside Interactive, Inc. ("Outside Interactive") entered into a sublease agreement whereby Charlotte’s Web, Inc. agreed to sublease to Outside Interactive, as subtenant, the entirety of the 42,191 of rentable square feet (consisting of Suite 300, Suite 100, and the Basement/Garden Level) under the 1600 Pearl Street Sublease Agreement commencing on June 1, 2021 and expiring on August 31, 2025 (the "Outside Interactive Sublease Agreement"). The Outside Interactive Sublease Agreement included a rent abatement period during the first seven months of the lease providing for $0 monthly rent. The average monthly installment for the term of the lease after the rent abatement period is $90,695. Upon receiving the landlord’s consent to the sublease, Outside Interactive delivered to Charlotte’s Web, Inc. an unconditional, irrevocable, and transferrable letter of credit in the amount of $500,000 to secure Outside Interactive’s full performance of its obligations under the Outside Interactive Sublease Agreement, naming Charlotte’s Web, Inc. as beneficiary. The sublease agreement with Outside Interactive has been terminated as of August 31, 2025. The foregoing description is qualified in its entirety by reference to the Outside Interactive Sublease Agreement.

Item 2 of the 10-K filed Mar 31, 2026.5

Leadership

Who has led Charlotte's Web Holdings, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (21)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • DirectorJeff E. Raborn named Jun 5, 202640
  • DirectorM. Borgia E. Walker named Jun 5, 202640
  • DirectorJean David Birch named Oct 18, 2022 to Nov 18, 202241

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • • Abacus Health Products, Inc. Delaware4
  • • Abacus Products, Inc. British Columbia4
  • • Abacus Wellness, Inc. Delaware4
  • • Charlotte’s Web, Inc. Delaware4

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

  1. Aug 20, 20268-K Entered a material agreement42
  2. Aug 13, 20268-K Results of operations43
  3. Jun 5, 20268-K Executive or director change44
  4. Jun 3, 20268-K Entered a material agreement; Ended a material agreement; Unregistered sale of shares45
  5. Jun 1, 20268-K Executive or director change; Shareholder vote; Other events46
  6. May 13, 20268-K Results of operations47
  7. Apr 1, 20268-K Entered a material agreement48
  8. Mar 31, 20268-K Other events49
  9. Mar 31, 20268-K Results of operations50
  10. Nov 12, 20258-K Results of operations51
  11. Oct 21, 20258-K Executive or director change52
  12. Sep 19, 20258-K Executive or director change53
  13. Sep 14, 2023New chief executive William J. Morachnick becomes CEO13
  14. Jan 4, 2022New chief executive Jacques Tortoroli becomes CEO14

Calendar

Coming up

  1. Around Nov 13, 2026Next results, estimated About a quarter after its last report. The company hasn't announced the date.

When it reported results

  1. Aug 13, 2026Reported quarterly or annual results43
  2. May 13, 2026Reported quarterly or annual results47
  3. Mar 31, 2026Reported quarterly or annual results50
  4. Nov 12, 2025Reported quarterly or annual results51
  5. Aug 13, 2025Reported quarterly or annual results54
  6. May 14, 2025Reported quarterly or annual results55
  7. Mar 19, 2025Reported quarterly or annual results56
  8. Nov 14, 2024Reported quarterly or annual results57

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

285 filings to the SEC since October 2021: 5 annual reports, 14 quarterly reports, 74 major events, 146 insider forms, 4 large holders, 3 private raises, 39 other. The latest 20:

  1. Oct 2, 20264 EDGAR
  2. Oct 2, 20264 EDGAR
  3. Sep 4, 20264 EDGAR
  4. Aug 20, 20268-K EDGAR
  5. Aug 13, 202610-Q EDGAR
  6. Aug 13, 20268-K EDGAR
  7. Jul 6, 20264 EDGAR
  8. Jul 6, 20264 EDGAR
  9. Jul 6, 20264 EDGAR
  10. Jul 6, 20264 EDGAR
  11. Jul 2, 20264 EDGAR
  12. Jun 5, 20268-K EDGAR
  13. Jun 5, 2026D EDGAR
  14. Jun 3, 20268-K EDGAR
  15. Jun 3, 20264 EDGAR
  16. Jun 3, 20264 EDGAR
  17. Jun 3, 20264 EDGAR
  18. Jun 3, 20263 EDGAR
  19. Jun 1, 20268-K EDGAR
  20. May 29, 2026SCHEDULE 13D/A EDGAR

The 285 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

9 open-market trades by officers, directors and large owners since October 2021: 8 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 3, 2026Kunkel Raymond J.Chief Operating OfficerBuy137,935$0.29$40.0KForm 4
Sep 2, 2025Kunkel Raymond J.Chief Operating OfficerBuy229,167$0.10$22.9KForm 4
May 30, 2025Kunkel Raymond J.Chief Operating OfficerBuy227,273$0.11$24.9KForm 4
Sep 3, 2024Kunkel Raymond J.Chief Operating OfficerBuy125,167$0.15$18.8KForm 4
Aug 30, 2024Kunkel Raymond J.Chief Operating OfficerBuy2,479$0.14$347Form 4
Aug 29, 2024Kunkel Raymond J.Chief Operating OfficerBuy8,100$0.14$1.1KForm 4
Aug 28, 2024Kunkel Raymond J.Chief Operating OfficerBuy10,000$0.14$1.4KForm 4
Aug 27, 2024Kunkel Raymond J.Chief Operating OfficerBuy2,000$0.14$280Form 4
Jul 2, 2024Morga AliciaSale510,134$0.16$81.6KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025William MorachnickChief Executive Officer62$567.3K$640.2K60
2025Raymond KunkelChief Operating Officer60$361.5K$559.7K60
2025Erika LindChief Financial Officer54$299.4K$443.1K60
2025Stephen RogersFormer Senior Vice President – General Counsel$205.4K$391.5K60
2024William MorachnickChief Executive Officer62$450.0K$675.6K60
2024Raymond KunkelChief Operating Officer60$300.0K$389.5K60
2024Stephen RogersFormer Senior Vice President – General Counsel$304.8K$380.5K60

Money raised

Private offerings the company reported to the SEC on Form D.

  1. May 28, 2026Raised $10 million in a private offering of equity Form D: 1 investor so far Form D
  2. Nov 14, 2022Raised $56.8 million in a private offering of securities Form D: 1 investor so far Form D
  3. Oct 11, 2022Raised $4.2 million in a private offering of equity Form D: 1 investor so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Financial Gravity Companies, Inc.208$680.0%New
Main Street Group, LTD100$330.0%No change
Leo H. Evart, Inc.3$10.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Charlotte's Web Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCharlotte's Web Holdings, Inc.1
  • CIK0001750155
  • Employer ID (EIN)98-15086335
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; not a shell company5
  • Incorporated inBritish Columbia5
  • Fiscal year endsDecember 311
  • Industry code (SIC)0100 Agricultural Production-Crops1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address700 Tech Court, Louisville, CO 800271
  • Phone1-720-617-73031
  • Shares outstanding271,291,529 as of Aug 11, 202612
  • Public float$13.5M as of Jun 30, 20255
  • AuditorPKF O’Connor Davies, LLP, New York, New York PCAOB ID 127; no auditor attestation of internal control over financial reporting5
  • On EDGAR sinceSep 7, 20181
  • Filings287 in all: 4 (111), 8-K (72), 3 (27), 10-Q (14), DEFA14A (10), 4/A (7), 10-K (5), D (5)1
    All 25 form types

    DEF 14A (5), ARS (4), UPLOAD (4), CORRESP (3), S-8 (3), 10-12G/A (2), 8-K/A (2), SC 13D (2), SCHEDULE 13D/A (2), SEC STAFF LETTER (2), 10-12G (1), 3/A (1), 424B3 (1), EFFECT (1), PRE 14A (1), S-3 (1), S-8 POS (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2026
    Quarterly report (10-Q) Aug 13, 2026
    Proxy statement (DEF 14A) Apr 16, 2026
    Latest 8-K (8-K) Aug 20, 2026

Risk factors and legal proceedings

The risks Charlotte's Web Holdings, Inc. names in Item 1A of its 10-K filed Mar 31, 2026: 76 risks under these headings, as written.5

  • Risks Relating to the Regulatory Environment
  • The regulatory environment surrounding hemp is uncertain, varies among jurisdictions, and is subject to change.
  • The future of hemp regulation at the Federal level is unclear.
  • The Company’s products are subject to numerous and diverse regulatory requirements which may restrict the Company’s ability to sell its product, and regulatory compliance costs may affect the Company’s business and financial results.
  • Compliance with changes in legal, regulatory and industry standards may adversely affect the Company’s business.
  • The Company is subject to regulations that could impact its ability to sell its product internationally.
  • Entry into international markets diverts management attention and requires financial resources that could be spent elsewhere and poses increased costs due to numerous banking, compliance, financial, legal, market, and reputational issues.
  • The designation of cannabinoids as a New Dietary Ingredient (NDI) or as an impermissible adulterant are uncertain.
  • The FDA interpretation of IND Preclusion could be disruptive to the Company’s ability to sell its products.
  • The FDA enforcement against the sale and marketing of CBD products under the FD&C Act could target the Company and adversely impact the Company’s business and financial position.
  • The FTC may take enforcement actions against companies selling CBD products, including the Company.
  • The DEA Interpretation of the 2018 Farm Bill could cause the DEA to take enforcement action against the Company’s intermediate hemp products.
The other 65 risks
  • Any inability to obtain required regulatory approval and permits could limit the Company’s ability to conduct its business.
  • The Company is subject to environmental, health and safety laws, compliance with such laws may be costly, and any failure to comply with such laws could negatively impact the Company’s results of operations or financial position.
  • Regulatory uncertainty with respect to anti-money laundering laws and regulations impact on the CBD and cannabis related businesses, if revised or resolved unfavorably to the Company’s interests, may have an adverse effect on the Company’s business.
  • The Company could be adversely affected by violations of the Corruption of Foreign Public Officials Act (Canada), the U.S. Foreign Corrupt Practices Act and other similar anti-bribery laws.
  • As a cannabis-related business, the Company may have difficulty accessing banking services due to the illegality of marijuana under federal law.
  • The Company may have difficulty accessing public and private capital and banking services, which could negatively impact its ability to finance its operations.
  • The Company could be liable for fraudulent or illegal activity by its employees, contractors and consultants resulting in significant financial losses due to claims against the Company.
  • Risks Relating to the Company’s Business and Industry
  • The Company faces security risks related to its physical facilities.
  • The Company depends on the success of its products, and those products may not achieve the desired market acceptance.
  • There is no assurance that the Company’s cash flows and debt or other financing will be sufficient to fund the Company’s operations.
  • The Company’s products have a stated shelf life and product inventory may reach its expiration prior to sale.
  • The Company’s quality control systems may not prove successful.
  • The Company depends on various third parties for the supply, manufacture, and testing of some of the Company’s products. No assurance can be given that these relationships will continue on favorable terms, or at all.
  • The Company’s manufacturers and suppliers must meet cGMP requirements and failure on their part to do so could have adverse consequences for the Company.
  • The Company’s manufacturers and suppliers must remain in compliance with the hemp production and manufacturing laws of the states in which they operate.
  • If product liability claims are brought against the Company, it could incur substantial liabilities.
  • The Company's operations and industry may be subject to reputational risk.
  • The Company is dependent upon agricultural production of hemp for part of the Company’s operations, which are subject to seasonal and weather-related risks.
  • There may be adverse consequences to the Company's end users should they test positive for trace amounts of THC attributed to use of the Company's products.
  • The Company may be unable to obtain or maintain farming contracts sufficient for its hemp cultivation needs.
  • Climate change could exacerbate certain of the risks inherent in the Company’s agricultural operations.
  • Hemp is subject to specific agricultural risks, which could negatively impact the Company’s cultivation efforts.
  • The Company relies on third-parties for the transportation of its hemp and hemp-derived products; any delay or failure by these third-parties to meet the Company’s transport needs could impact the Company’s operations and financial performance.
  • The Company faces intense competition.
  • Changing consumer preferences could impact the Company’s ability to attract and retain customers.
  • The Company depends on the popularity and acceptance of its brand portfolio.
  • Supply chain issues, including significant price fluctuations or shortages of materials, and distribution challenges may increase the Company’s cost of goods sold and cause its results of operations and financial condition to suffer.
  • The Company may not be able to successfully implement its growth strategy on a timely basis, or at all.
  • The market for the Company's products and industry is difficult to forecast due to limited and unreliable market data.
  • The Company depends on key personnel and its ability to attract and retain employees.
  • From time to time, the Company may rely on debt financing for some of its business activities, and there can be no assurance the Company will be able to access such credit, or that it will be able to comply with the terms of such credit.
  • The Company may have difficulty obtaining insurance to cover its operational risks.
  • The Company may be subject to growth-related risks, including capacity constraints and pressure on its internal systems and controls.
  • The Company may acquire other companies, which could divert management’s attention, result in additional dilution to the Company’s Shareholders and otherwise disrupt the Company and harm its operating results.
  • The Company’s intellectual property may be difficult to protect.
  • If the Company is unable to protect the confidentiality of its trade secrets, the value of its technology could be materially adversely affected and the business would be harmed.
  • Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies and the Company's patent protection could be reduced or eliminated for non-compliance with these requirements.
  • The Company may become involved in lawsuits to protect or enforce its patents or other intellectual property rights, which could be expensive, time-consuming and unsuccessful.
  • Third parties may initiate legal proceedings alleging that the Company is infringing, misappropriating or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of the business.
  • The Company is involved in litigation, including class action litigation, and there may be additional litigation in the future in which it will be involved.
  • Trade Secrets may be difficult to protect.
  • The Company’s status as a public benefit company may not result in the benefits that the Company anticipates.
  • As a public benefit company, the Company has a duty to balance a variety of interests that may result in actions that do not maximize Shareholder value.
  • As a public benefit company, the Company may be subject to increased legal proceedings concerning its duty to balance Shareholder and public benefit interests, the occurrence of which may have an adverse impact on the Company’s financial condition and results of operations.
  • The Company contracts with certain third parties for portions of its operations; should a third party be subject to insolvency or otherwise be unable or unwilling to perform their obligations to the Company, it could negatively impact the Company's operations.
  • Tariffs on imported packaging materials could increase costs.
  • Risks Relating to the Company’s Securities
  • The Company has a history of losses and may continue to incur losses in the future.
  • Debt and the Convertible Debenture Agreement that the Company has in place may limit other future potential strategic investor interests.
  • The Company has required and, in the future, may require additional financing to operate its business, and it may face difficulties acquiring additional financing on terms acceptable to the Company, if at all.
  • The Company has discretion in the use of proceeds from its securities issuances.
  • There is a limited market for the Company’s Common Shares.
  • The market price of the Company’s Common Shares and other listed securities may be volatile.
  • The Company does not intend to pay dividends on its Common Shares and, consequently, the ability of investors to achieve a return on their investment will depend entirely on appreciation in the price of the Company’s Common Shares.
  • The Company is a holding company and its earnings depend on the earnings and distributions of its subsidiaries.
  • Future sales of Common Shares by Shareholders, directors or officers could create volatility in the Company’s share price.
  • A small number of Shareholders may exercise significant influence on matters submitted to Shareholders for approval.
  • The Company may issue an unlimited number of shares, and additional issuances could dilute a Shareholder’s holdings.
  • Purchasers of the Company’s Common Shares may experience immediate and substantial dilution of their investment.
  • The elimination of monetary liability against the Company’s directors, officers, and employees under British Columbia law and the existence of indemnification rights for the Company’s obligations to its directors, officers, and employees may result in substantial expenditures by the Company and may discourage lawsuits against its directors, officers, and employees.
  • The Company’s Articles provide that the Supreme Court of British Columbia, Canada and the Court of Appeal of British Columbia, Canada shall, to the fullest extent permitted by law, be the sole and exclusive forum for derivative actions, actions relating to breaches of fiduciary duty, and other matters, creating a conflict with U.S. federal securities laws, which may limit the ability to obtain a favorable judicial forum for disputes with the Company.
  • The Company is subject to U.S. and other income tax and is treated as a U.S. domestic company for U.S. federal income tax purposes.
  • General Risk Factors
  • Investment in the Company’s Common Shares is speculative, involves risk, and there is no guarantee of a return.
  • Product recalls and returns could adversely affect the Company’s operating results and financial condition.
  • The Company may be subject to impairment of intangible and long-lived assets, which could adversely impact the Company’s financial results.
  • Certain employees or directors of the Company may have interests that conflict with those of the Company.

Legal proceedings

From time to time, the Company may be involved in various regulatory issues, claims and lawsuits arising in the ordinary course of business, none of which, in the opinion of management, is expected to have a material adverse effect on the Company’s results of operations or financial condition.

At present, the Company is not a party to any material pending legal proceedings, other than ordinary routine litigation incidental to the business. Nor is the Company or its property the subject of any legal proceedings, known or contemplated, that involve a claim for damages exclusive of interest and costs that meet or exceed 10% of its current assets.

The opening of Item 3, Legal Proceedings.5

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
    SEC EDGAROther events
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60